Article info

Download PDFPDF
Intravitreal dexamethasone implant use as first-line therapy for cancer-associated retinopathy

Authors

  1. Correspondence to Dr Joel Mudri; joel.mudri{at}health.wa.gov.au
View Full Text

Citation

Mudri J, Phagura RS, Lam W, et al
Intravitreal dexamethasone implant use as first-line therapy for cancer-associated retinopathy

Publication history

  • Accepted October 7, 2021
  • First published November 11, 2021.
Online issue publication 
November 11, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.